Convection-enhanced delivery of nanodiamond drug delivery platforms for intracranial tumor treatment

Nanomedicine. 2014 Feb;10(2):381-91. doi: 10.1016/j.nano.2013.07.013. Epub 2013 Aug 3.


This study examined a novel drug delivery system for treatment of malignant brain gliomas: DOX complexed with nanodiamonds (ND-Dox), and administered via convection-enhanced delivery (CED). Drug retention and toxicity were examined in glioma cell lines, and distribution, retention and toxicity were examined in normal rat parenchyma. Efficacy was assessed in a bioluminescence rodent tumor model. NDs markedly enhanced DOX uptake and retention in glioma cells. ND-Dox delivered via CED extended DOX retention and localized DOX toxicity in normal rodent parenchyma, and was significantly more efficient at killing tumor cells than uncomplexed DOX. Outcomes from this work suggest that CED of ND-Dox is a promising approach for brain tumor treatment.

From the clinical editor: In this paper, nanodiamonds were utilized to enhance delivery of DOX in a preclinical glioma model using a convection-enhanced delivery method, demonstrating remarkably enhanced efficacy.

Keywords: Convection-enhanced delivery (CED); Doxorubicin (Dox); Glioma; Nanodiamonds (NDs).

Publication types

  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't
  • Research Support, U.S. Gov't, Non-P.H.S.

MeSH terms

  • Animals
  • Apoptosis
  • Brain Neoplasms / drug therapy*
  • Cell Line, Tumor
  • Cell Proliferation
  • Cell Survival
  • Drug Carriers*
  • Glioma / drug therapy*
  • Humans
  • Male
  • Nanodiamonds*
  • Nanomedicine
  • Neoplasm Transplantation
  • Rats
  • Rats, Inbred F344
  • Tissue Distribution


  • Drug Carriers
  • Nanodiamonds